91
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Low perfusion index affects the difference in glucose level between capillary and venous blood

, , , , , , & show all
Pages 985-991 | Published online: 20 Nov 2014

Figures & data

Table 1 Descriptive statistics related to the participants

Figure 1 (A) Venous and capillary glucose level comparability in all patients with normal vital signs and low perfusion index (0–5) (n=67). (B) Venous and capillary glucose level comparability in patients with normal vital signs and high perfusion index (>5) (n=19).

Notes: (A) Passing and Bablok regression equation y =5.4648+0.9718x. Cusum test for linearity: P>0.10. (B) Passing and Bablok regression equation y =28.2272+0.7923x. Cusum test for linearity: P>0.05.
Abbreviations: CGL, capillary glucose level; VGL, venous glucose level; SD, standard deviation.
Figure 1 (A) Venous and capillary glucose level comparability in all patients with normal vital signs and low perfusion index (0–5) (n=67). (B) Venous and capillary glucose level comparability in patients with normal vital signs and high perfusion index (>5) (n=19).

Figure 2 (A) Venous and capillary glucose level comparability in patients with at least one abnormal vital sign finding and low perfusion index (n=131). (B) Venous and capillary glucose level comparability in patients with at least one abnormal vital sign finding and high perfusion index (n=57).

Notes: (A) Passing and Bablok regression equation y =13.8113+0.8679x. Cusum test for linearity: P>0.05. (B) Passing and Bablok regression equation y =10.2941+0.8916x. Cusum Test for Linearity: P>0.10.
Abbreviations: CGL, capillary glucose level; VGL, venous glucose level; SD, standard deviation.
Figure 2 (A) Venous and capillary glucose level comparability in patients with at least one abnormal vital sign finding and low perfusion index (n=131). (B) Venous and capillary glucose level comparability in patients with at least one abnormal vital sign finding and high perfusion index (n=57).

Figure 3 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with perfusion index between 0 and 5 (n=44). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with perfusion index between 0 and 5 (n=22).

Notes: (A) Passing and Bablok regression equation y =8.3621+0.9310x. Cusum test for linearity: P>0.10. (B) Passing and Bablok regression equation y =1.8347+1.0565x. Cusum test for linearity: P>0.10.
Abbreviations: CGL, capillary glucose level; VGL, venous glucose level; SD, standard deviation.
Figure 3 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with perfusion index between 0 and 5 (n=44). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with perfusion index between 0 and 5 (n=22).

Figure 4 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with perfusion index >5 (n=12). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with perfusion index >5 (n=7).

Notes: (A) Passing and Bablok regression equation y =11.3753+0.8528x. Cusum test for linearity: P>0.10. (B) Passing and Bablok regression equation y =56.1357+0.6953x. Cusum test for linearity: P>0.10.
Abbreviations: CGL, capillary glucose level; VGL, venous glucose level; SD, standard deviation.
Figure 4 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with perfusion index >5 (n=12). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with perfusion index >5 (n=7).

Figure 5 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with at least one abnormal vital sign finding and low perfusion index (n=72). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with at least one abnormal vital sign finding and low perfusion index (n=59).

Notes: (A) Passing and Bablok regression equation y =13.9138+0.8459x. Cusum test for linearity: P<0.05. (B) Passing and Bablok regression equation y =16.4853+0.8758x. Cusum Test for Linearity: P>0.10.
Abbreviations: CGL, capillary glucose level; VGL, venous glucose level; SD, standard deviation.
Figure 5 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with at least one abnormal vital sign finding and low perfusion index (n=72). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with at least one abnormal vital sign finding and low perfusion index (n=59).

Figure 6 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with at least one abnormal vital sign finding and high perfusion index (n=24). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with at least one abnormal vital sign finding and high perfusion index (n=33).

Notes: (A) Passing and Bablok regression equation y =7.0950+0.8450x. Cusum test for linearity: P>0.10. (B) Passing and Bablok regression equation y =9.1246+0.9208x. Cusum test for linearity: P>0.10.
Abbreviations: CGL, capillary glucose level; VGL, venous glucose level; SD, standard deviation.
Figure 6 (A) Venous and capillary glucose level comparability in younger patients, aged 18–65 years, with at least one abnormal vital sign finding and high perfusion index (n=24). (B) Venous and capillary glucose level comparability in older patients, aged >65 years, with at least one abnormal vital sign finding and high perfusion index (n=33).

Table 2 Summary of major results